Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial – JAMA Editorial: COVID-19 Infection—Preventing Clinical Deterioration Commentary: Fluvoxamine may prevent serious illness in COVID-19 patients, study suggests – Washington University School of Medicine  

The post Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19 appeared first on Links Medicus.